Investors Research Corp Amgen Inc Transaction History
Investors Research Corp
- $448 Million
- Q1 2025
A detailed history of Investors Research Corp transactions in Amgen Inc stock. As of the latest transaction made, Investors Research Corp holds 39 shares of AMGN stock, worth $10,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$10,715% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,286Shares Held
431MCall Options Held
6.85MPut Options Held
6.23M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.5 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.09 Billion0.31% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.59 Billion0.88% of portfolio
-
Capital International Investors Los Angeles, CA15.1MShares$4.16 Billion0.97% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $147B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...